Overview

The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The objective here is to determine that the efficiency of inhaled drug delivery can be improved by using a fine mist cloud of drug particles (as opposed to a coarse mist cloud of drug particles). This information will be valuable in designing new inhalers in order to improve their beneficial effects and reduce their side effects, by using the least possible drug dose to achieve a good patient response. .
Phase:
Phase 4
Details
Lead Sponsor:
Imperial College London
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone